I use skin substitutes a lot less frequently than I used to in the outpatient setting, but more frequently in the OR and they work great in covering tendon and bone in combination with NPWT. In the OR setting, it's mostly a single application (sometimes two) and then NPWT until granular as a bridge to STSG.
The new LCD draft was full of serious issues that weren't based on science. But I wrote to all 7 MACs with David Armstrong and Larry Lavery and they adopted 90% of our recommended changes. The final LCD (delayed as stated) supported evidence-based, best practices in wound care and wouldn't seriously impact patient access to skin substitutes, but it would have curtailed certain skin substitute companies' access to patients. The delay seems financially and politically motivated and not based on the science.